​

Tango Therapeutics Ownership | Who Owns Tango Therapeutics?

OverviewForecastRevenueFinancialsChart

Tango Therapeutics Ownership Summary

Tango Therapeutics is owned by 118.88% institutional investors, 4.95% insiders. Trv gp iv is the largest institutional shareholder, holding 12.54% of TNGX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.25% of its assets in Tango Therapeutics shares.

TNGX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTango Therapeutics118.88%4.95%-23.82%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Trv gp iv13.86M12.54%$116.46M
Farallon capital management10.76M9.73%$90.36M
Ecor1 capital10.63M9.62%$89.30M
Boxer capital management9.77M8.84%$82.08M
Tcg crossover management8.54M7.72%$71.70M
Boxer capital8.20M7.58%$70.34M
Woodline partners lp6.03M5.45%$50.65M
Siren5.88M5.32%$49.42M
Blackrock funding, inc. /de5.65M5.11%$47.43M
Nextech invest5.53M5.10%$17.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trv gp iv13.86M42.51%$116.46M
Boxer capital management9.77M26.16%$82.08M
Mass general brigham354.19K14.79%$3.04M
Nextech invest5.53M7.08%$46.49M
Ecor1 capital10.63M4.29%$89.30M
Boxer capital8.20M3.70%$70.34M
Tcg crossover management8.54M3.53%$71.70M
Nextech invest5.53M2.77%$17.10M
Allostery investments lp40.00K2.61%$204.80K
Gilead sciences4.85M2.28%$40.78M

Top Buyers

HolderShares% AssetsChange
Paradigm biocapital advisors lp3.09M0.74%3.09M
Point72 asset management2.92M0.04%2.92M
Siren5.88M1.93%2.52M
State street3.37M0.00%1.98M
Farallon capital management10.76M0.37%1.60M

Top Sellers

HolderShares% AssetsChange
Southpoint capital advisors lp---5.00M
Adage capital partners gp2.51M0.03%-3.39M
Trv gp iv13.86M42.51%-3.00M
Tcg crossover management8.54M3.53%-2.20M
Nantahala capital management1.81M0.53%-1.63M

New Positions

HolderShares% AssetsChangeValue
Paradigm biocapital advisors lp3.09M0.74%3.09M$25.92M
Point72 asset management2.92M0.04%2.92M$24.52M
Deep track capital, lp1.45M0.34%1.45M$12.22M
Logos global management lp950.00K0.72%950.00K$7.98M
Avoro capital advisors545.00K0.06%545.00K$4.58M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Nelson, van denburg & campbell wealth management group-12.00
True wealth design-16.00
Versant capital management-28.00
Corecap advisors-321.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202514117.50%131,410,6723.26%1180.90%8421.74%3317.86%
Jun 30, 2025118-127,240,30347.81%1151.89%6715.52%28-28.21%
Mar 31, 2025121-11.68%107,289,0950.80%971.01%59-28.92%3840.74%
Dec 31, 202471-41.80%37,625,298-62.92%340.40%41-25.45%13-63.89%
Sep 30, 20241224.27%101,468,8152.91%931.13%56-359.38%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.42M2.25%712.74K
Vanguard Total Stock Mkt Idx Inv2.16M1.94%-47.84K
iShares Russell 2000 ETF1.87M1.68%-
Fidelity Growth Compy Commingled Pl O1.69M1.58%-
Fidelity Growth Company Fund1.53M1.43%543.72K
T. Rowe Price Small-Cap Value1.54M1.39%-117.06K
Fidelity Small Cap Growth1.25M1.17%-
T. Rowe Price US Small-Cap Core Equity1.19M1.11%277.63K
T. Rowe Price Small-Cap Stock1.19M1.11%199.50K
SPDR® S&P Biotech ETF1.12M1.05%16.00K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 23, 2025Third Rock Ventures IV, L.P.-Sell$4.85M
Sep 25, 2025Third Rock Ventures IV, L.P.-Sell$4.01M
Sep 16, 2025Third Rock Ventures IV, L.P.-Sell$2.56M
Sep 05, 2025Third Rock Ventures IV, L.P.-Sell$4.50M
Sep 08, 2025Third Rock Ventures IV, L.P.-Sell$608.63K

Insider Transactions Trends

DateBuySell
2025 Q4-1
2025 Q3-6
2025 Q2--
2025 Q1-8
2024 Q427

TNGX Ownership FAQ

Who Owns Tango Therapeutics?

Tango Therapeutics shareholders are primarily institutional investors at 118.88%, followed by 4.95% insiders and -23.83% retail investors. The average institutional ownership in Tango Therapeutics's industry, Biotech Stocks , is 45.22%, which Tango Therapeutics exceeds.

Who owns the most shares of Tango Therapeutics?

Tango Therapeutics’s largest shareholders are Trv gp iv (13.86M shares, 12.54%), Farallon capital management (10.76M shares, 9.73%), and Ecor1 capital (10.63M shares, 9.62%). Together, they hold 31.89% of Tango Therapeutics’s total shares outstanding.

Does Blackrock own Tango Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tango Therapeutics.

Who is Tango Therapeutics’s biggest shareholder by percentage of total assets invested?

Trv gp iv is Tango Therapeutics’s biggest shareholder by percentage of total assets invested, with 42.51% of its assets in 13.86M Tango Therapeutics shares, valued at 116.46M$.

Who is the top mutual fund holder of Tango Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Tango Therapeutics shares, with 2.25% of its total shares outstanding invested in 2.42M Tango Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools